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Abstract
Background: Trimethylation of the Nε-lysine residues in a protein is one of the most important
events of posttranslational modifications. Simple methods for rapid detection and isolation of the
Nε-trimethylated protein species are needed. This report introduces a novel method to prepare
the affinity purified antibody specific for the Nε-trimethylated lysine (tMeK). The applications of the
purified antibody are also reported in this paper.
Methods: We generated the methylated keyhole limpet heomocyanin (KLH) under controlled
chemical methylation reaction using CH3I and used it as an immunogen to raise anti-methylated
lysine antibodies. The tMeK specific antibody was selectively isolated using a two-step affinity
chromatography in which the mMeK/dMeK specific antibodies were removed and the tMeK
specific antibody was captured. Finally, the eluted anti-tMeK antibody was characterized.
Results: The ELISA results indicated that the antibody reacted only to tMeK but not to mono- and
dimethyllysine. Western-blot results showed that the Nε-trimethylated proteins were detected in
both animal tissue and cultured cells and that the antibody signal could be competitively inhibited
with free tMeK.
Conclusion: The specific tMeK antibody we developed is useful for one-step isolation of proteins
with Nε-trimethyllysine residues and also for the detection, identification and localization of
proteins with trimethyllysine residues in the cells.
Background
Similar to protein phosphorylation and acetylation, pro-
tein methylation is one of the most important post-trans-
lational modifications in regulating protein functions.
Perhaps, histone is the best known target for protein
methylation. Histone lysine methylation plays an impor-
tant role in the regulation of chromatin structure, gene
expression and DNA damage [1,2]. Histones and p53
could be enzymatically methylated by a family of protein
lysine methyltransferases [3,4] and demethylated enzy-
matically by a family of demethylases [5,6]. The single
lysine residue could exist as mono-, di-, tri-methylated
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and unmethylated forms with different functional conse-
quences [7]. Trimethylation of a specific lysine residue in
histone H3 is reported to be associated with inactive X
chromosome [5,8,9].
Most of the reports on protein methylation are related to
histone methylation and a few of them related to the p53
methylation [10]. Other methylated proteins are still
largely unknown. As protein methylation may be associ-
ated with embryonic development and diseases [1], the
proteomic survey of the methylated protein patterns in
different developmental stages and human diseases
become an important area in epigenetic research. In this
paper, we report a novel method to generate and purify a
pan-specific, Nε-trimethyllysine antibody (anti-tMeK),
which could be used as a simple tool for the study of pro-
tein trimethylation profiles. We generated the methylated
keyhole limpet heomocyanin (KLH) under controlled
chemical methylation reaction using CH3I and used it as
an immunogen to raise anti-methylated lysine antibodies.
The tMeK specific antibody was selectively isolated using
a two-step affinity chromatography in which the mMeK/
dMeK specific antibodies were removed and the tMeK spe-
cific antibody was captured. Finally, the eluted anti-tMeK
antibody was characterized and we demonstrated that the
anti-tMeK antibody could be used as a functional tool for
the detection of the trimethylated proteins using Western
blot and immunofluorescence and isolation of trimethyl-
ated proteins using immunoprecipitation.
Results
Purification and ELISA characterization
Ideally, a trimethyllysine-specific antibody (anti-tMeK)
should be highly specific and has strong affinity to tri-
methyllysine (tMeK) but not to monomethyllysine
(mMeK) and dimethyllysine (dMeK). The rationale of
developing such an antibody is to use a synthetic trimeth-
ylated protein, in which, the Nε-amino group of the lysine
side chain was trimethylated, as an immunogen. Methyl-
ation of the ε-amine groups of a protein using iodometh-
ane (CH3I) generates mono-, di- and trimethylated lysine
residues in a protein (Figure 1a). The yield for trimethyl-
ated species was increased by performing the reaction at
higher pH and in prolonged reaction time (see Materials
and Methods). The highly immunogenic protein, KLH,
was used for the methylation reaction. The dialyzed meth-
ylated KLH was immunized to the rabbit to generate anti-
methyllysine antibodies. After 60 days from initial immu-
nization, immune serum was prepared and ELISA test was
carried out to test the titer. The serum has 50% maximum
OD titer at 1:50,000 to tMeK-BSA conjugates, approxi-
mately 1:2,000 and 1:10,000 to mMeK-BSA and dMeK-
BSA conjugates respectively (data not shown). The meth-
ylated KLH was synthesized while the mMeK, dMeK and
tMeK used in ELISA were purchased commercially. The
primary ELSIA results indicated that the anti-methylated
KLH immune serum cross-reacted with each form of the
methylated lysine peptides.
The rabbits immunized with methylated KLH contained
specific antibodies against all the methylated species. The
strategy for isolating and purifying the tMeK-specific anti-
body is illustrated in Figure 1b. The immune serum was
initially passed through a mMeK/dMeK affinity column.
The antibodies bound to the column was eluted and
Generation of anti-trimethyllysine antibody Figure 1
Generation of anti-trimethyllysine antibody. A. The reaction 
scheme for chemical synthesis of KLH with trimethyllysine 
residues. B. The scheme for strategic affinity purification of 
the trimethyllysine-specific antibody. The antibody in serum 
cross-reacted to monomethyllysine and dimethyllysine is 
removed by the mMeK/dMeK affinity column. The remaining 
trimethyllysine-specific antibody in the serum is further puri-
fied using tMeK affinity column.Proteome Science 2008, 6:2 http://www.proteomesci.com/content/6/1/2
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determined to be about 10 mg. SDS-PAGE staining sug-
gested the eluted proteins were mainly IgG with over 90%
purity (data not shown). The yield for mMeK/dMeK anti-
bodies was approximately 50 µg/mL of serum.
After removal of the mMeK/dMeK antibodies, the
immune serum flowed through the mMeK/dMeK affinity
column was then passed through the tMeK affinity col-
umn. The antibody bound to the tMeK column was eluted
and determined to be approximately 50 mg. SDS-PAGE
staining indicated that the IgG purity is over 90% (data
not shown). The yield for tMeK-specific antibodies was
approximately 250 µg/mL.
The specificity of the purified anti-trimethyllysine to
immobilized mMeK-, dMeK- and tMeK-BSA was deter-
mined by indirect ELISA (Figure 2). BSA is used here to
facilitate the immobilization of the small methyllysine
molecule onto the plastic surface of the micro plate. The
chemical reaction for the preparation of three forms of
methyllysine-BSA conjugates is identical. The primary
antibody dilution buffer also contains 1% of BSA. The
ELISA results showed that the tMeK-specific antibody did
not react well with both mMeK and dMeK-BSA but
strongly to tMeK.
Immunoblotting detection and immunoprecipitation of 
the proteins with Nε-trimethyllysine residues in cell culture 
and animal tissue
Figure 3a showed that the anti-tMeK antibody recognized
various proteins in the human melanoma cells. Those
protein bands recognized by the anti-tMeK antibody
could be completely inhibited by the free tMeK suggesting
that the antibody is Nε-trimethyllysine-specific and the
protein bands recognized by the anti-tMeK are trimethyl-
ated.
There are 7 major protein bands (14, 17, 19, 30, 32, 40,
and 54 kD) recognized by anti-tMeK antibody according
to the Western blot (Figure 3a). The strongest bands rec-
ognized by tMeK-specific antibody were 17 kD and 40 kD.
The film exposure time for the blot was less than 1 min.
Some of the proteins with lower expression recognized by
the antibody may not be revealed under such conditions.
Since lysine residues of histones can also be acetylated, we
tested if the histone deacetylase inhibitor trichostatin A
(TSA) would have an effect on trimethylation of cellular
proteins. Our data showed that TSA increased the trimeth-
ylation level, particularly for the 14 kD and 18 kD pro-
teins.
In the mouse spleen lysate, approximately 5 major protein
bands were recognized by the anti-tMeK antibody. The
methylated protein pattern is somewhat similar to
melanoma cell lysate. The major bands recognized are 14,
17, 30, 54, and 70 kD (Figure 3b). The protein bands rec-
ognized by the antibody could also be completely inhib-
ited by free tMeK.
Immunoprecipitation in undenatured condition is impor-
tant for protein isolation and purification. Approximately
200 µg of anti-tMeK antibody was utilized to isolate pos-
sible trimethylated proteins. Using the anti-tMeK HRP
conjugates for the Western blot analysis of the anti-tMeK
immunoprecipitated proteins, the massive interference of
IgG bands produced by the secondary anti-rabbit IgG HRP
could be eliminated. No IgG signal was observed in the
competitive inhibition by tMeK BSA (Figure 3b). The
Western blot results however, showed different pattern of
proteins. In the crude lysate, only 5 major protein bands
were recognized by the anti-tMeK HRP while the signal in
the crude lysate was significantly enriched in the IP sam-
ple. However, the 70 kD proteins detected in crude lysate
could not be isolated by anti-tMeK antibody (Figure 3b).
In the IP sample, anti-tMeK could capture more than 6
protein bands with 14–16, 17, 20–23, 30, 40, and 54 kD.
The protein band at 70 kD was only captured by tMeK in
crude lysate. The 20–23 kD, 30 kD proteins were signifi-
cantly enriched while the 20–23 kD bands were not visi-
ble in the crude lysates. Apparently all the IP protein
bands were blocked with the presence of free tMeK mole-
cule, suggesting that the IP proteins contained tMeK-resi-
dues.
To confirm whether the proteins immunoprecipitated by
the antibody we generated are indeed trimethylated, we
The specificity of the tMeK-purified antibody in an ELSIA test Figure 2
The specificity of the tMeK-purified antibody in an ELSIA 
test. The ELISA reaction of the purified tMeK-specific anti-
body was carried out with immobilized tMek-BSA, mMeK-
BSA, or dMeK-BSA.Proteome Science 2008, 6:2 http://www.proteomesci.com/content/6/1/2
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used three well established site-specific anti-trimethylly-
sine antibodies against histone H3 (H3K4me3,
H3K9me3, H3K27me3) for Western blotting. Figure 3c
shows that all three trimethylated species of histone H3
could be detected in the proteins immunoprecipitated
with our antibody.
Immunofluorescent staining
Using the human melanoma cells as working model, the
FITC conjugated anti-tMeK antibody could strongly stain
the nuclei of the cell and weakly in the cytoplasm. Brighter
spots of the staining could also be observed in the nuclei
(Figure 4). The fluorescent staining signal could be signif-
icantly inhibited with the presence of the tMeK, suggest-
ing that staining signal is trimethyllysine-specific.
Discussion and Conclusion
Protein methylation is an important event of post-transla-
tional modification. The goal of proteomic studies is to
reveal that how the protein modification plays its role in
gene expression, protein interaction and signal transduc-
tion. To understand the roles of protein methylation, sim-
ple and rapid methods for detection, identification,
isolation and localization of the methylated proteins is
needed. Development of an antibody specific for the
methylated proteins is one of the important aspects to
facilitate the proteomic survey of the protein methylation.
The pan-specific antibodies against mMeK and dMeK
have been commercially available. The purpose of this
research is to develop a specific antibody against tMeK
which could be applied to the proteomic survey and to the
basic research of bioscience.
In our previous report [11], we used modified protein as
immunogen and antibody against single modified amino
acid could be raised and isolated through specific immu-
noaffinity chromatography. To produce an antibody
against single molecule of trimethyllysine, a trimethylated
protein may be the best choice as immunogen. Enzymatic
synthesis of trimethylated protein may not be a good
choice for generation of such immunogen as the enzyme
reaction is highly site-specific. Chemically trimethylated
proteins may produce desired epitopes in an immuno-
genic protein. Reductive methylation of proteins using
formaldehyde followed by mild reduction with
cyanoborohydride makes this possible. However, the
products mainly consist of mono- and di-methylated
lysine instead of trimethyllysine [12]. We therefore sought
to use CH3I to methylate the Nε-amino group of lysine
residues in a protein at high pH (pH > 9). Primary and sec-
Western blot and immunoprecipitation analysis of proteins from human melanoma cells using the anti-tMeK antibody Figure 3
Western blot and immunoprecipitation analysis of proteins from human melanoma cells using the anti-tMeK antibody. A. Cells 
treated with or without TSA were lysed for Western blot (50 µg/lane) using the trimethyllysine-purified antibody, with and 
without the presence of free tMeK. B. Western blot analysis of the anti-tMeK immunoprecipitated proteins from the crude 
lysate of the mouse spleen using anti-tMeK HRP conjugates (0.25 µg/ml). The signal was competitively inhibited by the free 
tMeK (10 µg/ml). C. Western blot analysis of immunopreciptates by IgG control or anti-tMek antibody with H3K4me3, 
H3K9me3, or H3K27me3 antibodies.Proteome Science 2008, 6:2 http://www.proteomesci.com/content/6/1/2
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ondary amines are readily methylated under this condi-
tion. The Nε-methylation products are controlled by the
pH, time and temperature of the reactions. A conven-
tional high immunogenic protein KLH was methylated
with CH3I at pH > 9, 35°C for more than 6 h. Presumably,
the higher in pH and temperature, longer reaction time,
the more trimethylamine species will be generated. The
resulting methylated immunogen may yield more tri-
methylated protein specific antibodies.
The initial ELISA titration of the crude serum indicated
that the population of the antibodies against KLH meth-
ylated by CH3I has higher affinity for the trimethyllysine
(tMeK). Subsequently, the immunoaffinity chromatogra-
phy also demonstrated that our rationale is correct.
Approximately 80% (50 mg) of the methyllysine specific
antibodies specifically bind to tMeK, while only about
20% (10 mg) of the antibodies bind to mMeK/dMeK col-
umn. The ELISA data (Figure 2) showed that the antibody
purified with tMeK (anti-MeK) only recognized the tMeK-
BSA, not mMeK- or dMeK-BSA, suggesting that the anti-
tMeK antibody is highly specific.
The ELSIA data provide us the information that this anti-
body is specific for tMeK not mMeK or dMeK. Using
human melanoma cell culture as working model, Western
blot analysis indicated that multiple proteins with differ-
ent molecular weight range from 14 kD to 54 kD could
easily be detected with the anti-tMeK-specific antibody
(Figure 3a). Similar finding was also observed when the
antibody was applied to the protein extract of the mouse
tissue extract (Figure 3b). The protein bands recognized
by this tMeK-specific antibody could be completely inhib-
ited by the presence of free tMeK, suggesting the antibody
could be specifically used for detection of the proteins
with tMeK residues. The best known trimethylated pro-
teins are histones, particularly the histone H3 [2,13,14].
The Western blot results of both cultured cells and animal
tissue indicated that the 17 kD band may correspond to
histone H3. In addition, using the well established site-
specific anti-trimethyllysine antibodies against histone
H3 confirmed the presence of histone H3 in the immuno-
precipitates isolated with our antibody. There are many
protein bands recognized by anti-tMeK not only in West-
ern blot but also in immunoprecipitation. The results
imply that many other trimethylated proteins remain uni-
dentified.
In order to study the trimethylation profile of the pro-
teins, methods for rapid isolation of the trimethylated
species is needed. Immunoaffinity chromatography or IP
with anti-tMeK is one of the most efficient methods for
this purpose. Immunoprecipitation studies (Figure 3b
&3c) showed that this tMeK specific antibody could cap-
ture the trimethylated species efficiently. Most of the tri-
methylated proteins in the crude lysate recognized in the
Western blot detection system could also be specifically
isolated from the crude lysate by immunoprecipitation
and some of them could be significantly enriched by
immunoprecipitation implying the potential use of this
anti-tMeK antibody in isolating trimethylated proteins for
proteomics study.
Immunofluorsecent staining of human melanoma cells
with this anti-tMeK showed strong staining in the nuclei
(histone associated) and weak signal in the cytosol. The
immunofluorescent signal of the antibody was blocked by
free tMeK, suggesting the antibody staining signal is
highly specific for tMeK. The immunofluorscent staining
result correlates well with the fact that the lysine residues
of histones could be trimethylated at multiple sites and
the expression level of histones is usually high and stable.
The bright spots of the nuclear immunofluorescent stain-
ing could be explained by the fact that some histones asso-
ciated with the chromosome maybe heavily trimethylated
[8]. Those spots may also be the heterochromatin in
silenced region of the genome [4].
Immunofluorescence staining of the human melanoma cells  using tMeK-specific antibody Figure 4
Immunofluorescence staining of the human melanoma cells 
using tMeK-specific antibody. Cells treated with or without 
TSA (200 ng/ml) for 16 h were fixed with formaldehyde and 
permeabilized with 1% triton X-100. The cells were stained 
with 10 µg/ml anti-tMeK-FITC antibody with and without the 
presence of free tMeK (10 µg/ml). The image was captured 
with the Zeiss fluorescence microscope equipped with 
Northern Eclipse imaging software with an exposure time of 
100 ms. The picture shows the representative images of the 
staining.Proteome Science 2008, 6:2 http://www.proteomesci.com/content/6/1/2
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Protein methylation is one of the important post-transla-
tional modifications. The role of the protein methylation
in protein functions is not completely understood. Pro-
teomic studies of the protein methylation pattern in dif-
ferent cell cycle stages and disease states, in response to
gene expression regulation and drug treatment would be
interesting. Using the tMeK-specific antibody for Western
blot, the trimethylated protein patterns could be detected
and identified. Using immunoaffinity-capture techniques,
trimethylated proteins could be specifically isolated by
this tMeK-specific antibody and further identified through
peptide sequence analysis, Western blot or ELISA screen-
ing, microarray screening and mass spectrometry database
screening. Presumably, this antibody can also selectively
capture the trimethylated peptide fragments as a result of
the protease digestion of purified proteins. Therefore, this
could facilitate the proteomic survey of the trimethylated
proteins and identify the specific site of trimethylation.
Similar approach has been reported using acetyllysine-
specific antibody to identify the acetylated proteins in the
cell through the immunoaffinity-capture technique and
MS analysis [15].
In summary, CH3I is a good choice for chemical trimeth-
ylation of proteins as such immunogen yields more anti-
bodies against tMeK than the antibodies against mMeK
and dMeK. Single molecule of methylated lysine could be
used as immobilized affinity ligand to selectively purify
the specific population of the polyclonal antibody against
each specific form of Nε-methyllysine. The tMeK specific
antibody prepared using this method is proven to be use-
ful for detection, identification, isolation and localization
of the Nε-trimethylated proteins.
Methods
Methylation of KLH
All reagents except mentioned were purchased from
Sigma-Aldrich (St. Louis, MO). 25 mg of KLH was dis-
solved in 10 ml of 0.5 M Na2HPO4, then 10 µl of the
iodomethane solution was added every 30 min at 35°C
for 2 h. The reaction was incubated at 35°C for another 4
h. Saturated Na2CO3 was added to maintain the pH of the
reaction greater than pH 9. The reaction was stopped with
50 µl of the 2-mercaptoethanol at room temperature for
30 min. The methylated KLH was then dialyzed against
PBS 4 times at 2-h intervals. After dialysis, the total pro-
tein concentration was determined using the bicin-
choninic acid kit (Sigma) as described by the supplier.
Immunization
The methylated KLH (0.5 mg/rabbit) was immunized to
three rabbits (New Zealand species) with complete Fre-
und adjuvant. The rabbits were boost with 0.25 mg meth-
lylated KLH each with incomplete Freund adjuvant in 14
days, 35, and 56 days after the initial immunization,
respectively. The rabbits were bled for serum preparation
60 days after the initial immunization.
ELISA
5 mg of mMeK, dMeK and tMeK were dissolved in 1 ml of
0.1 M Na2CO3. 5 µl of 70% glutaraldehyde was added at
room temperature for 1 min; then all the reaction mixture
was transferred to 10 ml of BSA (2 mg/ml in 0.1 M
Na2CO3) in a 50 ml centrifuge tube. The reaction was
incubated at 35°C for 4 h then cooled to 4°C. 10 mg of
solid sodium cyanoborohydride was added to each reac-
tion. Each reaction mixture was then dialyzed against 500
ml of PBS for four times at 2-h interval. The conjugates
were stored in aliqouts at 4°C before use.
mMeK, dMeK and tMeK-BSA conjugates were diluted to
20 µg/ml in 0.1 M Na2CO3. The ELISA plate was coated
with 100 µl of methylated BSA conjugates in each well
and was incubated at room temperature for overnight.
The plate was washed with PBST (PBS containing 0.04%
Tween 20) and blocked with 100 µl/well of 2.5% BSA at
room temperature for 2 h. The plate was washed with
PBST for three times.
The serum was titrated from 1:1,000 in each methyllysine-
BSA plate in 2-fold serial dilution. The purified anti-tMeK
antibody was titrated in plates coated with mMeK-, dMeK-
and tMeK-BSA. Samples were run in triplicates. The start-
ing concentration of the anti-tMeK is 250 ng/ml in PBST
containing 1% BSA and was diluted in a 2-fold serial dilu-
tion. The primary antibody was incubated for 60 min and
washed with PBST for 4 times. Then, anti-rabbit IgG HRP
conjugates (0.25 µg/ml) in PBST containing 1% BSA were
added and the reaction was incubated at room tempera-
ture for 30 min. After washing with PBST for 4 times, 100
µl/well of HRP substrate TMB was added for color devel-
opment. The color reaction was stopped in 20 min with
20 µl of 1N HCl and absorbance at OD450 nm was meas-
ured.
Affinity purification of Anti-tMeK antibody
10 ml of agarose beads (Sepharose CL4B) was suspended
in 25 ml of 0.1 M acetate buffer (pH 6.5), and 200 mg of
the sodium periodate was added at 35°C for 2 h to oxidize
the agarose to yield aldehyde functional groups. The
beads were washed with the 400 ml of the acetate buffer
(pH4.5) then with 100 ml of distilled water. 5 mg of
mMeK and dMeK and 15 mg of tMeK were dissolved in 1
ml of 0.1 M Na2CO3. The coupling reaction was per-
formed by adding mMeK, dMeK and tMek, respectively,
into the oxidized agarose (W/V = 1/2) at 35°C for 2 h then
cool to 4°C. Then, 100 mg of the solid sodium
cyanoborohydride was added to each reaction and incu-
bated overnight. The beads were washed sequentially with
100 ml of distilled water and stored at 4°C.Proteome Science 2008, 6:2 http://www.proteomesci.com/content/6/1/2
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The scheme for the affinity purification of tMeK-specific
antibody was illustrated in Figure 1. 10 ml of mMeK and
10 ml of dMeK immobilized agarose (20 ml in total) were
packed into one glass column (2.5 × 10 cm) and 30 ml of
the tMeK agarose into another one glass column (2.5 × 10
cm). The column was washed with 200 ml PBST then 10
ml control blank rabbit serum was allowed to pass
through each column and washed with 100 ml of PBST
and 50 ml of the 3% acetic acid. The columns were then
equilibrated with 50 ml of PBS.
200 ml of the immune serum was initially passed through
the 20 ml mMeK/dMeK column at a flow rate of 5 ml/
min. The column was initially washed with 200 ml of
PBST then with 50 ml of 2 M NaCl. The antibody was
eluted from the column with 3% acetic acid and collected
on ice. After 5 ml void volume, 25 ml of eluent was col-
lected and 3 g of ammonia sulfate was added per 10 ml of
eluent to precipitate the eluted antibody. The solution was
continuously stirred until all ammonia sulfate was dis-
solved. The solution was placed at 4°C overnight and the
antibody was precipitated by centrifugation. The column
was washed with PBST again then equilibrated with PBS.
The flow through was then passed through the same col-
umn again until all the mMeK/dMeK specific antibodies
were removed by the column.
The mMeK/dMeK column adsorbed flow through was
then passed through a 30 ml tMeK column at a flow rate
of 5 ml/min. The column was initially washed with 250
ml of PBST then with 100 ml of 2 M NaCl. The bound
antibody was eluted with 50 ml 3% acetic acid. After 8 ml
void volume, 35 ml of eluent was collected, and 3 g of
ammonia sulfate/10 ml of eluent was added immediately
to precipitate the eluted antibody. The tube was incubated
at 4°C overnight and the antibody was precipitated by
centrifugation.
The precipitated antibody is dialyzed against PBS and sub-
jected to SDS-PAGE characterization and protein determi-
nation using human IgG as a standard.
Antibody conjugation
20 mg of HRP was dissolved in 4 ml of citrate buffer (pH
6.5) and 5 mg of sodium periodate was added and incu-
bated at 35°C for 30 min. The reaction was stopped by
passing the mixture through a 15 ml G25 Sephadex col-
umn. The brown color fraction of HRP was collected and
stored at 4°C.
2 mg of the purified antibody was added in 0.5 ml of 0.1
M Na2CO3 and mixed with 1 mg of the activated HRP at
35°C for 15 min then cooled to 4°C. 1 mg of sodium
borohydride was added and incubated overnight. Sodium
borohydride was removed by passing the solution
through 15 ml of G25 Sephadex column equilibrated with
PBS. The brown HRP fraction was collected and was
stored in presence of 50% glycerol and 10 mg/ml BSA -
20°C.
2 mg of the purified antibody was added in 0.5 ml of 0.1
M Na2CO3. 1 mg of the FITC was dissolved in 50 µl of
DMSO. 10 µl of the dissolved FITC was added to the anti-
body solution, vortexed and incubated at room tempera-
ture for 30 min. The reaction was stopped by adding 10 µl
of saturated Tris and then passed though a 15 ml G25
Sephadex column equilibrated with PBS. The yellow
FITC-labeled antibody fraction was collected and stored
in presence of 50% glycerol and 10 mg/ml BSA at -20°C.
Cell culture
Melanoma MMRU cells, a gift of Dr. R. Byers, Boston Uni-
versity, were cultured with Dulbecco's Modified Eagle's
Medium (Gibco) supplemented with 10% fetal bovine
serum (Hyclone), 100 units/ml penicillin and 100 µg/ml
streptomycin in 5% CO2 atmosphere at 37°C. For trichos-
tatin A (TSA) treatment, MMRU cells were treated with
200 ng/ml TSA for 16 h.
Immunoprecipitation
A mouse spleen was crunched and homogenized with
lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl,
0.02% sodium azide, 0.1% SDS, 1% NP-40, 0.5% sodium
deoxycholate, 100 µg/ml phenylmethylsulphonyl fluo-
ride, 1× protease inhibitor), and the lysate was centrifuged
at 12,000 × g for 5 min. The supernatant was used for both
IP and western blot. 100 µl of Protein A was packed in a
mini-column and anti-tMeK antibody (200 µg) in PBS
was pre-immobilized to the Protein A beads by passing
the antibody through the Protein A bead column 4 times
and washed with PBST. The crude lysate of the mouse
spleen (5 mg) was passed through the anti-tMeK pre-fixed
Protein A beads once, washed with PBST extensively,
eluted with 200 µl of hot 2× SDS-loading buffer and the
eluent was collected.
Western blot
Whole cell lysate was prepared from MMRU cells by lyz-
ing the cells in lysis buffer and sonicated. Cell debris was
removed by centrifugation at 12,000 × g for 10 min and
the supernatant was recovered. Protein concentration was
quantified by Protein Assay (Bio-Rad, Hercules, CA). 50
µg of proteins and 20 µl of IP sample were loaded for SDS-
PAGE, transferred to polyvinylidene difluoride mem-
brane, blocked in 5% BSA in PBST and probed with HRP-
conjugated anti-tMeK antibody at 1:1,000 dilution with
or without 10 µg/ml tMeK. Signals were developed by ECL
system (Amersham, Piscataway, NJ) and visualized by
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Immunofluorescent staining
Subconfluent MMRU cells seeded in a 6-well plate with or
without HDAC inhibitor treatment were fixed and perme-
abilized with 1% formaldehyde and 0.5% Triton X-100
for 10 min and blocked with 10 mg/ml BSA for 1 h at
room temperature. Cells were stained with FITC-conju-
gated anti-tMeK antibody (10 µg/ml) with or without 10
µg/ml tMeK for 1 h at room temperature. Photos were
taken with Zeiss fluorescence microscope equipped with
Northern Eclipse imaging software with an exposure time
of 100 ms.
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